To enhance our insights into the prognostic validity of the five-gene signature, we examined the expression of ATP6AP1, SLC7A5, EPDR1, SDC1, and PIGR in 13 paired BC samples, comparing them with their adjacent non-tumor tissues through RT-PCR. This evidence concerns the gene SLC7A5 and breast cancer.